These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32169995)

  • 1. Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014.
    Saito E; Hori M; Matsuda T; Yoneoka D; Ito Y; Katanoda K
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1222-1228. PubMed ID: 32169995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia.
    Luo Q; Yu XQ; Kahn C; Egger S; Patel MI; Grogan PB; Caruana M; Canfell K; Smith DP; O'Connell DL
    Cancer Epidemiol; 2022 Jun; 78():102159. PubMed ID: 35447540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.
    Cook MB; Hurwitz LM; Geczik AM; Butler EN
    Eur Urol; 2021 Jan; 79(1):33-41. PubMed ID: 33092896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
    Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program.
    Patasius A; Smailyte G
    Int J Environ Res Public Health; 2019 Dec; 16(23):. PubMed ID: 31816821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014.
    Innos K; Baburin A; Kotsar A; Eiche IE; Lang K
    Scand J Urol; 2017 Dec; 51(6):442-449. PubMed ID: 29092653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in lung cancer incidence by gender, histological type and stage at diagnosis in Japan, 1993 to 2015: A multiple imputation approach.
    Nguyen PT; Katanoda K; Saito E; Hori M; Nakayama T; Matsuda T
    Int J Cancer; 2022 Jul; 151(1):20-32. PubMed ID: 35138642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions.
    Parry MG; Sujenthiran A; Cowling TE; Charman S; Nossiter J; Aggarwal A; Clarke NW; Payne H; van der Meulen J
    Cancer Epidemiol; 2019 Feb; 58():44-51. PubMed ID: 30463041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
    Li J; Siegel DA; King JB
    Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.
    Herget KA; Patel DP; Hanson HA; Sweeney C; Lowrance WT
    Cancer Med; 2016 Jan; 5(1):136-41. PubMed ID: 26628287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality.
    Vutuc C; Waldhoer T; Madersbacher S; Micksche M; Haidinger G
    Eur J Cancer Prev; 2001 Oct; 10(5):425-8. PubMed ID: 11711757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of recent trends in prostate cancer incidence and mortality.
    Dennis LK; Resnick MI
    Prostate; 2000 Mar; 42(4):247-52. PubMed ID: 10679753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in prostate cancer in Canada.
    LeBlanc AG; Demers A; Shaw A
    Health Rep; 2019 Apr; 30(4):12-17. PubMed ID: 30994922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis.
    Haifler M; Neheman A; Zisman A
    Clin Genitourin Cancer; 2020 Aug; 18(4):e368-e373. PubMed ID: 32089472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
    Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
    BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer incidence and mortality in Navarre (Spain).
    Etxeberria J; Guevara M; Moreno-Iribas C; Burgui R; Delfrade I; Floristán Y; Montesino M; Ardanaz E
    An Sist Sanit Navar; 2018 Apr; 41(1):9-15. PubMed ID: 29358783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
    Liu X; Yu C; Bi Y; Zhang ZJ
    Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics.
    Pakzad R; Rafiemanesh H; Ghoncheh M; Sarmad A; Salehiniya H; Hosseini S; Sepehri Z; Afshari-Moghadam A
    Asian Pac J Cancer Prev; 2016; 17(2):839-43. PubMed ID: 26925689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening.
    Oki R; Ito K; Suzuki R; Fujizuka Y; Arai S; Miyazawa Y; Sekine Y; Koike H; Matsui H; Shibata Y; Suzuki K
    Int J Cancer; 2018 Oct; 143(7):1611-1619. PubMed ID: 29696637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.